, P. Soubeyran designed the research

M. Swayden, G. Alzeeb, R. Masoud, Y. Berthois, F. Silvy et al.,

S. Audebert and L. , Camoin performed the mass spectrometry analysis

, Hannouche and H. Vachon performed the RNA sequencing experiment and analysis

O. Gayet, M. Bigonnet, J. Roques, and N. , Dusetti provided material and help with patient-derived xenograft-related data

R. Masoud and A. , Carrier helped in designing, performing, and analyzing the redox reaction state of cells

J. , Iovanna and P. Soubeyran directed the work

M. ,

J. L. Swayden, Iovanna, and P. Soubeyran analyzed the data

M. , Swayden and P. Soubeyran wrote the manuscript

G. Schneider, J. T. Siveke, F. Eckel, and R. M. Schmid, Pancreatic cancer: basic and clinical aspects, Gastroenterology, vol.128, pp.1606-1625, 2005.

R. L. Siegel, K. D. Miller, J. , and A. , CA Cancer J. Clin, vol.68, pp.7-30, 2018.

T. Conroy, F. Desseigne, M. Ychou, O. Bouché, R. Guimbaud et al., FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer, N. Engl. J. Med, vol.364, pp.1817-1825, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00598658

V. Hoff, D. D. Ervin, T. Arena, F. P. Chiorean, E. G. Infante et al., Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine, N. Engl. J. Med, vol.369, pp.1691-1703, 2013.

A. Adamska, O. Elaskalani, A. Emmanouilidi, M. Kim, N. B. Razak et al., Molecular and cellular mechanisms of chemoresistance in pancreatic cancer, Adv. Biol. Regul, vol.68, pp.77-87, 2018.

K. E. Krueger and S. Srivastava, Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics, Mol. Cell. Proteomics, vol.5, pp.1799-1810, 2006.

M. Hochstrasser, Origin and function of ubiquitin-like proteins, Nature, vol.458, pp.422-429, 2009.

D. Hoeller and I. Dikic, Targeting the ubiquitin system in cancer therapy, Nature, vol.458, pp.438-444, 2009.

G. Goldstein, M. Scheid, U. Hammerling, D. H. Schlesinger, H. D. Niall et al., Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells, Proc. Natl. Acad. Sci. USA, vol.72, pp.11-15, 1975.

C. M. Pickart and M. J. Eddins, Ubiquitin: structures, functions, mechanisms, Biochim. Biophys. Acta, vol.1695, pp.55-72, 2004.

Y. Ye and M. Rape, Building ubiquitin chains: E2 enzymes at work, Nat. Rev. Mol. Cell Biol, vol.10, pp.755-764, 2009.

S. M. Nijman, M. P. Luna-vargas, A. Velds, T. R. Brummelkamp, A. M. Dirac et al., A genomic and functional inventory of deubiquitinating enzymes, Cell, vol.123, pp.773-786, 2005.

R. Yau and M. Rape, The increasing complexity of the ubiquitin code, Nat. Cell Biol, vol.18, pp.579-586, 2016.

L. Cappadocia and C. D. Lima, Ubiquitin-like protein conjugation: structures, chemistry, and mechanism, Chem. Rev, vol.118, pp.889-918, 2018.

A. C. Vertegaal, Uncovering ubiquitin and ubiquitin-like signaling networks, Chem. Rev, vol.111, pp.7923-7940, 2011.

V. Hietakangas, J. Anckar, H. A. Blomster, M. Fujimoto, J. J. Palvimo et al., PDSM, a motif for phosphorylation-dependent SUMO modification, Proc. Natl. Acad. Sci. USA, vol.103, pp.45-50, 2006.

L. Bedford, J. Lowe, L. R. Dick, R. J. Mayer, and J. E. Brownell, Ubiquitin-like protein conjugation and the ubiquitinproteasome system as drug targets, Nat. Rev. Drug Discov, vol.10, pp.29-46, 2011.

T. Bonacci, S. Audebert, L. Camoin, E. Baudelet, G. Bidaut et al., Identification of new mechanisms of cellular response to chemotherapy by tracking changes in post-translational modifications by ubiquitin and ubiquitin-like proteins, J. Proteome Res, vol.13, pp.2478-2494, 2014.

H. De-thé, C. Lavau, A. Marchio, C. Chomienne, L. Degos et al., The PML-RAR a fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR, Cell, vol.66, pp.675-684, 1991.

C. Gurrieri, P. Capodieci, R. Bernardi, P. P. Scaglioni, K. Nafa et al., Loss of the tumor suppressor PML in human cancers of multiple histologic origins, J. Natl. Cancer Inst, vol.96, pp.269-279, 2004.

V. Lallemand-breitenbach and H. De-thé, PML nuclear bodies: from architecture to function, Curr. Opin. Cell Biol, vol.52, pp.154-161, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02441939

T. H. Shen, H. K. Lin, P. P. Scaglioni, T. M. Yung, and P. P. Pandolfi, The mechanisms of PML-nuclear body formation, Mol. Cell, vol.24, pp.331-339, 2006.

O. Maguire, C. Collins, K. O'loughlin, J. Miecznikowski, and H. Minderman, Quantifying nuclear p65 as a parameter for NF-kB activation: correlation between imagestream cytometry, microscopy, and western blot, Cytometry A, vol.79, pp.461-469, 2011.

L. W. Yuan and J. E. Gambee, Histone acetylation by p300 is involved in CREB-mediated transcription on chromatin, Biochim. Biophys. Acta, vol.1541, pp.161-169, 2001.

P. Duconseil, M. Gilabert, O. Gayet, C. Loncle, V. Moutardier et al., Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma, Am. J. Pathol, vol.185, pp.1022-1032, 2015.

S. Tessier, N. Martin-martin, H. De-thé, A. Carracedo, and V. Lallemand-breitenbach, Promyelocytic leukemia protein, a protein at the crossroad of oxidative stress and metabolism, Antioxid. Redox Signal, vol.26, pp.432-444, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02441961

G. Bossis and F. Melchior, Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes, Mol. Cell, vol.21, pp.349-357, 2006.

J. L. Best, S. Ganiatsas, S. Agarwal, A. Changou, P. Salomoni et al., SUMO-1 protease-1 regulates gene transcription through PML, Mol. Cell, vol.10, pp.843-855, 2002.

N. Hattersley, L. Shen, E. G. Jaffray, and R. T. Hay, The SUMO protease SENP6 is a direct regulator of PML nuclear bodies, Mol. Biol. Cell, vol.22, pp.78-90, 2011.

C. Ma, B. Wu, X. Huang, Z. Yuan, K. Nong et al., SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9, Tumour Biol, vol.35, pp.12729-12735, 2014.

Z. G. Wang, L. Delva, M. Gaboli, R. Rivi, M. Giorgio et al., Role of PML in cell growth and the retinoic acid pathway, Science, vol.279, pp.1547-1551, 1998.

B. Bian, M. Bigonnet, O. Gayet, C. Loncle, A. Maignan et al., Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts, EMBO Mol. Med, vol.9, pp.482-497, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01787567

B. J. Tauro, D. W. Greening, R. A. Mathias, S. Mathivanan, H. Ji et al., Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids, Mol. Cell. Proteomics, vol.12, pp.587-598, 2013.

C. R. Silvers, H. Miyamoto, E. M. Messing, G. J. Netto, and Y. Lee, Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer, Oncotarget, vol.8, pp.91199-91208, 2017.

S. N. Hurwitz, M. A. Rider, J. L. Bundy, X. Liu, R. K. Singh et al., Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers, Oncotarget, vol.7, pp.86999-87015, 2016.

C. Zhang, Q. Ji, Y. Yang, Q. Li, W. et al., Exosome: function and role in cancer metastasis and drug resistance, Technol. Cancer Res. Treat, vol.17, p.1533033818763450, 2018.